Corrigendum to “TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases” [Heliyon Volume 10, Issue 16, August 2024, Article e36532]
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Heliyon |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025016305 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850123460189093888 |
|---|---|
| author | Tao Lin Xusheng Tang Wanli Yang Hainan Yang Zhaoming Zhou Zhijie Chen Yongqin Zeng Weiping Hong Minting Ye Linbo Cai Da Liu Minying Li Lei Wen |
| author_facet | Tao Lin Xusheng Tang Wanli Yang Hainan Yang Zhaoming Zhou Zhijie Chen Yongqin Zeng Weiping Hong Minting Ye Linbo Cai Da Liu Minying Li Lei Wen |
| author_sort | Tao Lin |
| collection | DOAJ |
| format | Article |
| id | doaj-art-b00a8d3c76cc4bfa99dd3ad3dea9a67b |
| institution | OA Journals |
| issn | 2405-8440 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj-art-b00a8d3c76cc4bfa99dd3ad3dea9a67b2025-08-20T02:34:35ZengElsevierHeliyon2405-84402025-05-011110e4324710.1016/j.heliyon.2025.e43247Corrigendum to “TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases” [Heliyon Volume 10, Issue 16, August 2024, Article e36532]Tao Lin0Xusheng Tang1Wanli Yang2Hainan Yang3Zhaoming Zhou4Zhijie Chen5Yongqin Zeng6Weiping Hong7Minting Ye8Linbo Cai9Da Liu10Minying Li11Lei Wen12Department of Neurosurgery, Guangdong Sanjiu Brain Hospital, Guangzhou, ChinaDepartment of Radiation Oncology, Shanghai GoBroad Cancer Hospital, Shanghai, ChinaThe First Rehabilitation Hospital of Shanghai, Department of Medical Genetics, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Critical Care Medicine, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, 358 Datong Road, Pudong New District, Shanghai, 200137, ChinaDepartment of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, ChinaDepartment of Neurosurgery, Guangdong Sanjiu Brain Hospital, Guangzhou, ChinaDepartment of Neurosurgery, Guangdong Sanjiu Brain Hospital, Guangzhou, ChinaDepartment of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, ChinaDepartment of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, ChinaDepartment of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, ChinaDepartment of Neurosurgery, Guangdong Sanjiu Brain Hospital, Guangzhou, China; Corresponding author.Department of Radiation Oncology, Zhongshan People's Hospital, Zhongshan, China; Corresponding author.Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, 253 Gongye Dadao, Guangdong, 510280, Guangzhou, China; Department of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China; Corresponding author. Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, 253 Gongye Dadao, Guangdong, 510280, Guangzhou, China.http://www.sciencedirect.com/science/article/pii/S2405844025016305 |
| spellingShingle | Tao Lin Xusheng Tang Wanli Yang Hainan Yang Zhaoming Zhou Zhijie Chen Yongqin Zeng Weiping Hong Minting Ye Linbo Cai Da Liu Minying Li Lei Wen Corrigendum to “TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases” [Heliyon Volume 10, Issue 16, August 2024, Article e36532] Heliyon |
| title | Corrigendum to “TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases” [Heliyon Volume 10, Issue 16, August 2024, Article e36532] |
| title_full | Corrigendum to “TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases” [Heliyon Volume 10, Issue 16, August 2024, Article e36532] |
| title_fullStr | Corrigendum to “TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases” [Heliyon Volume 10, Issue 16, August 2024, Article e36532] |
| title_full_unstemmed | Corrigendum to “TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases” [Heliyon Volume 10, Issue 16, August 2024, Article e36532] |
| title_short | Corrigendum to “TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases” [Heliyon Volume 10, Issue 16, August 2024, Article e36532] |
| title_sort | corrigendum to tp53 and egfr amplification are negative predictors of overall survival in patients diagnosed with non small cell lung cancer with brain metastases heliyon volume 10 issue 16 august 2024 article e36532 |
| url | http://www.sciencedirect.com/science/article/pii/S2405844025016305 |
| work_keys_str_mv | AT taolin corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT xushengtang corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT wanliyang corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT hainanyang corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT zhaomingzhou corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT zhijiechen corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT yongqinzeng corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT weipinghong corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT mintingye corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT linbocai corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT daliu corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT minyingli corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 AT leiwen corrigendumtotp53andegframplificationarenegativepredictorsofoverallsurvivalinpatientsdiagnosedwithnonsmallcelllungcancerwithbrainmetastasesheliyonvolume10issue16august2024articlee36532 |